Applied Therapeutics Ownership | Who Owns Applied Therapeutics?
Applied Therapeutics Ownership Summary
Applied Therapeutics is owned by 27.72% institutional investors, 4.90% insiders, and 67.38% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 64.40% of APLT shares. T. Rowe Price Small-Cap Value is the top mutual fund, with 4.71% of its assets in Applied Therapeutics shares.
APLT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Applied Therapeutics | 27.72% | 4.90% | 67.38% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 9.30M | 64.40% | $7.96M |
| Schonfeld strategic advisors | 8.76M | 60.70% | $7.50M |
| Vanguard group | 5.55M | 38.44% | $4.75M |
| T. rowe price investment management | 5.42M | 37.56% | $4.64M |
| Deutsche bank ag\ | 4.47M | 30.95% | $3.84M |
| Simplify asset management | 2.82M | 19.52% | $2.41M |
| Alyeska investment group | 2.71M | 18.76% | $2.32M |
| Tang capital management | 2.43M | 16.82% | $2.08M |
| Geode capital management | 2.08M | 14.44% | $1.78M |
| State street | 2.07M | 14.32% | $1.77M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Propel bio management | 11.29M | 6.41% | $5.52M |
| Stempoint capital lp | 2.21M | 3.03% | $10.33M |
| Knoll capital management | 7.80M | 2.48% | $3.81M |
| Vestal point capital, lp | 11.50M | 0.40% | $5.62M |
| Vr adviser | 5.57M | 0.23% | $2.72M |
| Tang capital management | 2.43M | 0.14% | $2.08M |
| Artal group | 1.01M | 0.12% | $4.71M |
| Simplify asset management | 2.82M | 0.12% | $2.41M |
| Rock springs capital management lp | 1.92M | 0.06% | $1.64M |
| Schonfeld strategic advisors | 8.76M | 0.04% | $7.50M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Schonfeld strategic advisors | 8.76M | 0.04% | 8.42M |
| Blackrock | 6.57M | 0.00% | 5.58M |
| T. rowe price investment management | 5.42M | 0.00% | 5.21M |
| Blackrock funding, inc. /de | 9.30M | 0.00% | 2.35M |
| Knoll capital management | 7.80M | 2.48% | 2.00M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Franklin resources | 2.00M | 0.00% | -4.80M |
| Vr adviser | 5.57M | 0.23% | -4.42M |
| Frazier life sciences management | - | - | -2.29M |
| Adage capital partners gp | 1.96M | 0.00% | -2.15M |
| Siren | - | - | -1.63M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 243.20K | - | 243.20K | $208.23K |
| Ubs asset management americas | 119.03K | - | 119.03K | $101.89K |
| Private advisor group | 40.30K | 0.00% | 40.30K | $34.51K |
| Cantor fitzgerald, l. p. | 25.00K | 0.00% | 25.00K | $21.41K |
| China universal asset management | 24.67K | 0.00% | 24.67K | $21.12K |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| National bank of canada /fi/ | -4.00 |
| Headlands | -23.00 |
| Geowealth management | -27.00 |
| Advisor group | -70.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 7 | -94.62% | 37,179,368 | -67.70% | 27 | 0.00% | 2 | -97.53% | 2 | -92.31% |
| Dec 31, 2024 | 127 | -11.19% | 109,297,179 | -3.04% | 757 | 0.12% | 79 | -8.14% | 26 | -18.75% |
| Sep 30, 2024 | 143 | 41.58% | 112,721,880 | 9.20% | 780 | 11.51% | 85 | 37.10% | 33 | 37.50% |
| Jun 30, 2024 | 101 | 1.00% | 103,226,978 | 9.86% | 82 | 1.47% | 62 | -7.46% | 24 | 50.00% |
| Mar 31, 2024 | 100 | 12.36% | 93,965,703 | 53.04% | 74 | 1.41% | 67 | 15.52% | 16 | 45.45% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Small-Cap Value | 6.47M | 4.71% | -1.39K |
| Simplify Propel Opportunities ETF | 4.49M | 3.17% | - |
| Vanguard US Total Market Shares ETF | 3.15M | 2.71% | - |
| T. Rowe Price U.S. SC Value Eq Tr-Z | 3.65M | 2.66% | 1.76M |
| T. Rowe Price U.S. SC Value Eq Tr-D | 3.65M | 2.58% | 1.76M |
| Vanguard Total Stock Mkt Idx Inv | 3.10M | 2.19% | - |
| iShares Russell 2000 ETF | 2.91M | 2.05% | 1.42K |
| SPDR® S&P Biotech ETF | 1.74M | 1.49% | 24.74K |
| Janus Henderson Global Life Sciences D | 1.62M | 1.39% | 1.30M |
| Janus Henderson Glb Life Scn I2 USD | 1.29M | 1.11% | 1.29M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 04, 2025 | Perfetti Riccardo | Chief Medical Officer | Sell | $4.56K |
| Mar 04, 2025 | Funtleyder Leslie D. | See Remarks | Sell | $6.38K |
| Mar 04, 2025 | Chinoporos Constantine | See Remarks | Sell | $196.68 |
| Feb 06, 2025 | Funtleyder Leslie D. | See Remarks | Sell | $14.00K |
| Feb 06, 2025 | Perfetti Riccardo | Chief Medical Officer | Sell | $52.51K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 6 |
| 2024 Q4 | - | - |
| 2024 Q3 | - | 5 |
| 2024 Q2 | - | 5 |
APLT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools